MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12974-025-03387-6

Медицинская библиотека · Journal of neuroinflammation · 2025

The protective PLCγ2-P522R variant mitigates Alzheimer's disease-associated pathologies by enhancing beneficial microglial functions.

Takalo Mari, Jeskanen Heli, Rolova Taisia, Kervinen Inka, Hellén Marianna, Heikkinen Sami, Koivisto Hennariikka, Jokivarsi Kimmo, Müller Stephan A, Koivumäki Esa-Mikko, Mäkinen Petra, Juopperi Sini-Pauliina, Willman Roosa-Maria, Sinisalo Rosa, Hoffmann Dorit, Jäntti Henna, Peitz Michael, Fließbach Klaus, Kuulasmaa Teemu, Natunen Teemu, Kemppainen Susanna, Poutiainen Pekka, Leinonen Ville, Malm Tarja, Martiskainen Henna, Ramirez Alfredo, Haapasalo Annakaisa, Lichtenthaler Stefan F, Tanila Heikki, Haass Christian, Rinne Juha, Koistinaho Jari, Hiltunen Mikko

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Phospholipase C gamma 2, proline 522 to arginine (PLCγ2-P522R) is a protective variant that reduces the risk of Alzheimer's disease (AD). Recently, it was shown to mitigate β-amyloid pathology in a 5XFAD mouse model of AD. Here, we investigated the protective functions of the PLCγ2-P522R variant in a less aggressive APP/PS1 mouse model of AD and assessed the underlying cellular mechanisms using mouse and human microglial models.

METHODS

The effects of the protective PLCγ2-P522R variant on microglial activation, AD-associated β-amyloid and neuronal pathologies, and behavioral changes were investigated in PLCγ2-P522R knock-in variant mice crossbred with APP/PS1 mice. Transcriptomic, proteomic, and functional studies were carried out using microglia isolated from mice carrying the PLCγ2-P522R variant. Finally, microglia-like cell models generated from human blood and skin biopsy samples of PLCγ2-P522R variant carriers were employed.

RESULTS

The PLCγ2-P522R variant decreased β-amyloid plaque count and coverage in female APP/PS1 mice. Moreover, the PLCγ2-P522R variant promoted anxiety in these mice. The area of the microglia around β-amyloid plaques was also increased in mice carrying the PLCγ2-P522R variant, while β-amyloid plaque-associated neuronal dystrophy and the levels of certain cytokines, including IL-6 and IL-1β, were reduced. These alterations were revealed through [18F]FEPPA PET imaging and behavioral studies, as well as various cytokine immunoassays, transcriptomic and proteomic analyses, and immunohistochemical analyses using mouse brain tissues. In cultured mouse primary microglia, the PLCγ2-P522R variant reduced the size of lipid droplets. Furthermore, transcriptomic and proteomic analyses revealed that the PLCγ2-P522R variant regulated key targets and pathways involved in lipid metabolism, mitochondrial fatty acid oxidation, and inflammatory/interferon signaling in acutely isolated adult mouse microglia and human monocyte-derived microglia-like cells. Finally, the PLCγ2-P522R variant also increased mitochondrial respiration in human iPSC-derived microglia.

CONCLUSIONS

These findings suggest that the PLCγ2-P522R variant exerts protective effects against β-amyloid and neuronal pathologies by increasing microglial responsiveness to β-amyloid plaques in APP/PS1 mice. The changes observed in lipid/fatty acid and mitochondrial metabolism revealed by the omics and metabolic assessments of mouse and human microglial models suggest that the protective effects of the PLCγ2-P522R variant are potentially associated with increased metabolic capacity of microglia.

Для цитирования: Takalo Mari, Jeskanen Heli, Rolova Taisia, Kervinen Inka, Hellén Marianna, Heikkinen Sami, Koivisto Hennariikka, Jokivarsi Kimmo, Müller Stephan A, Koivumäki Esa-Mikko, Mäkinen Petra, Juopperi Sini-Pauliina, Willman Roosa-Maria, Sinisalo Rosa, Hoffmann Dorit, Jäntti Henna, Peitz Michael, Fließbach Klaus, Kuulasmaa Teemu, Natunen Teemu, Kemppainen Susanna, Poutiainen Pekka, Leinonen Ville, Malm Tarja, Martiskainen Henna, Ramirez Alfredo, Haapasalo Annakaisa, Lichtenthaler Stefan F, Tanila Heikki, Haass Christian, Rinne Juha, Koistinaho Jari, Hiltunen Mikko. The protective PLCγ2-P522R variant mitigates Alzheimer's disease-associated pathologies by enhancing beneficial microglial functions.. Journal of neuroinflammation. 2025. DOI: 10.1186/s12974-025-03387-6.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.